Timothy A. Chan

Also affiliated with Cleveland Clinic Lerner College of Medicine, Center for Neuroscience and Regenerative Medicine, Research Network (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

16.4Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Papers

Driven by 83 papers — median percentile 80. Top paper: “An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics”.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3283

N/A

1.9DataRank · unranked

55 citations

Renzo G. DiNatale, Alejandro Sánchez, Ritesh R. Kotecha, Sounak Gupta, Fengshen Kuo +18 more

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0053

N/A

1.2DataRank · unranked

33 citations

Renzo G. DiNatale, Diego Chowell, Chirag Krishna, Vladimir Makarov, Cristina Valero +21 more

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058

Top 20%

1.0DataRank

Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

My personal mutanome: a computational genomic medicine platform for searching network perturbing alleles linking genotype to phenotype

Genome biology(2021)10.1186/s13059-021-02269-3

Top 25%

0.803DataRank

Top 25%22 citations

Junfei Zhao, Jiansong Fang, William R. Martin, Lang Li, Ruth Nussinov +4 more

Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas

Science Advances(2020)10.1126/sciadv.aaz3221

N/A

0DataRank · unranked

108 citations

Aaron T. Wild, Şevin Turcan, Wei Wu, Carlie Sigel, David S. Klimstra +6 more

Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma

Cancers(2020)10.3390/cancers12051221

N/A

0DataRank · unranked

76 citations

Tsutomu Kawaguchi, Li Yan, Xuan Peng, Qianya Qi, Luc G.T. Morris +5 more

Genetic and environmental determinants of human TCR repertoire diversity

Immunity & Ageing(2020)10.1186/s12979-020-00195-9

N/A

0DataRank · unranked

70 citations

Diego Chowell, Mithat Gönen, Yuval Elhanati, Timothy A. Chan, Chirag Krishna

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response

Nature Communications(2020)10.1038/s41467-020-17965-0

N/A

0DataRank · unranked

66 citations

Kyrollis Attalla, Renzo G. DiNatale, Irina Ostrovnaya, Jessica Flynn, Kyle A. Blum +12 more

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa095

N/A

0DataRank · unranked

65 citations

Dana L. Casey, Yue Christine Lu, Margaret Hannum, Zhigang Zhang, Xinmao Song +26 more

Diverse Neoantigens and the Development of Cancer Therapies

Seminars in Radiation Oncology(2020)10.1016/j.semradonc.2019.12.001

N/A

0DataRank · unranked

15 citations

Tanaya A. Purohit, Timothy A. Chan, Raghvendra M. Srivastava

Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology

Human Molecular Genetics(2020)10.1093/hmg/ddaa203

N/A

0DataRank · unranked

6 citations

A. Ari Hakimi, Timothy A. Chan, Renzo G. DiNatale

A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19

ChemRxiv(2020)10.26434/chemrxiv.12579137

N/A

0DataRank · unranked

30 citations

Yuan Hou, Jiayu Shen, Asha Kalianpur, Joe Zein, Daniel A. Culver +13 more

A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19

ChemRxiv(2020)10.26434/chemrxiv.12579137.v1

N/A

0DataRank · unranked

19 citations

Yuan Hou, Jiayu Shen, Asha Kalianpur, Joe Zein, Daniel A. Culver +13 more

IRF8 Governs Tumor-Associated Macrophage Control of T Cell Exhaustion

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.12.989731

N/A

0DataRank · unranked

4 citations

Fengshen Kuo, Ming Liu, Kristelle J. Capistrano, Mytrang Do, Ruth A. Franklin +15 more

Multimodal Single-Cell Omics Analysis of COVID-19 Sex Differences in Human Immune Systems

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.01.407007

N/A

0DataRank · unranked

1 citations

Yadi Zhou, Michaela U. Gack, Justin D. Lathia, Asha Kallianpur, Reena Mehra +6 more

TGFβ Suppresses Type 2 Immunity to Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.04.977629

N/A

0DataRank · unranked

0 citations

Fengshen Kuo, Kristelle J. Capistrano, Davina Kang, Briana G. Nixon, Wei Shi +11 more

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Nature Communications(2021)10.1038/s41467-021-20935-9

N/A

0DataRank · unranked

458 citations

Mark Lee, Douglas R. Hoen, Kate Weiss, Daniel W. Kelly, Prasad S. Adusumilli +24 more

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

Cancer Cell(2021)10.1016/j.ccell.2021.03.007

N/A

0DataRank · unranked

444 citations

Renzo G. DiNatale, Fengshen Kuo, Raghvendra M. Srivastava, Lynda Vuong, Diego Chowell +28 more

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Nature Biotechnology(2021)10.1038/s41587-021-01070-8

N/A

0DataRank · unranked

272 citations

Seong‐Keun Yoo, Cristina Valero, Alessandro Pastore, Chirag Krishna, Mark Lee +29 more

The association between tumor mutational burden and prognosis is dependent on treatment context

Nature Genetics(2021)10.1038/s41588-020-00752-4

N/A

0DataRank · unranked

262 citations

Mark Lee, Douglas R. Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel +22 more

Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights

Nature Communications(2021)10.1038/s41467-021-27106-w

N/A

0DataRank · unranked

44 citations

Gregory Knapp, Avinash Sharma, Walid K. Chatila, Olukayode Arowolo, Olalekan Olasehinde +35 more

Multimodal single-cell omics analysis identifies epithelium–immune cell interactions and immune vulnerability associated with sex differences in COVID-19

Signal Transduction and Targeted Therapy(2021)10.1038/s41392-021-00709-x

N/A

0DataRank · unranked

30 citations

Yadi Zhou, Michaela U. Gack, Justin D. Lathia, Asha Kallianpur, Reena Mehra +6 more

Current Prospects for Treatment of Solid Tumors via Photodynamic, Photothermal, or Ionizing Radiation Therapies Combined with Immune Checkpoint Inhibition (A Review)

Pharmaceuticals(2021)10.3390/ph14050447

N/A

0DataRank · unranked

59 citations

Timothy A. Chan, Tayyaba Hasan, Edward V. Maytin, Sanjay Anand

Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0442

N/A

0DataRank · unranked

20 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Han, Fengshen Kuo +12 more

Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0224

N/A

0DataRank · unranked

13 citations

Yongxing Gong, Fengshen Kuo, Vladimir Makarov, Ed Reznik, Gouri J. Nanjangud +10 more

Resource-efficient pooled sequencing expands translational impact in solid tumors

Kidney Cancer Journal(2021)10.52733/kcj18n2.a1

N/A

0DataRank · unranked

1 citations

Roy Mano, Vladimir Makarov, Nicole Rusk, Esther Drill, Andrew Winer +13 more

Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.25.445197

N/A

0DataRank · unranked

4 citations

Sanju Sinha, Cristina Valero, Alejandro A. Schäffer, Kenneth Aldape, Kevin Litchfield +4 more

Activation of Adaptive Immune Cells is an Early Response to Hyperthermic Intraperitoneal Chemotherapy Treatment in Ovarian Cancer

Research Square(2021)10.21203/rs.3.rs-701286/v1

N/A

0DataRank · unranked

1 citations

Tyler Alban, Max Horowitz, Danielle Chau, Zahraa Alali, Emily Esakov +11 more

Resource-efficient pooled sequencing expands translational impact in solid tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.06.447265

N/A

0DataRank · unranked

0 citations

Roy Mano, Vladimir Makarov, Nicole Rusk, Esther Drill, Andrew Winer +13 more

The Immunogenetic Basis of Idiopathic Bone Marrow Failure Syndromes: A Paradox of Similarity and Self-Presentation

medRxiv(2021)10.1101/2021.05.28.21258028

N/A

0DataRank · unranked

0 citations

Carmelo Gurnari, Hassan Awada, Ashwin Kishtagari, Sunisa Kongkiatkamon, Laila Terkawi +16 more

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity

Nature Genetics(2022)10.1038/s41588-022-01108-w

N/A

0DataRank · unranked

79 citations

Nadeem Riaz, Robert Samstein, Mark Lee, Vladimir Makarov, Cristina Valero +29 more

H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2114324119

N/A

0DataRank · unranked

50 citations

Ritika Tiwari, Sirvan Khalighi, Ankur Chakravarthy, Wei Yuan, Michael Berk +12 more

Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade

npj Precision Oncology(2022)10.1038/s41698-022-00267-7

N/A

0DataRank · unranked

48 citations

Diego Chowell, Cristina Valero, Luc G.T. Morris, Timothy A. Chan, Seong‐Keun Yoo

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types

Cancer Research(2022)10.1158/0008-5472.can-21-2542

N/A

0DataRank · unranked

43 citations

Sanju Sinha, Cristina Valero, Alejandro A. Schäffer, Kenneth Aldape, Kevin Litchfield +4 more

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0925

N/A

0DataRank · unranked

33 citations

Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo +31 more

Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy

Journal of Clinical Investigation(2022)10.1172/jci154945

N/A

0DataRank · unranked

30 citations

Winston Vuong, Timothy A. Chan, Ahmed Halima

Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005328

N/A

0DataRank · unranked

19 citations

Thomas H. Pulliam, Natalie V. Longino, Song Y. Park, Kimberly S. Smythe, Vladimir Makarov +11 more

Solving the puzzle of what makes immunotherapies work

Trends in cancer(2022)10.1016/j.trecan.2022.06.011

N/A

0DataRank · unranked

13 citations

Timothy A. Chan, Xiaoxiao Ma

MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4607

N/A

0DataRank · unranked

12 citations

Karla V. Ballman, Matt D. Galsky, Michael J. Morris, Ronald C. Chen, Timothy A. Chan +9 more

479 Expression of Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) on CD4+/CD8+ T cells may associate with pathological characteristics of different types of cancer

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0479

N/A

0DataRank · unranked

0 citations

Hieu Minh Ta, Cassandra Gilmour, Timothy A. Chan, Keman Zhang, Li Wang +2 more

Immunosurveillance in clinical cancer management

CA A Cancer Journal for Clinicians(2023)10.3322/caac.21818

N/A

0DataRank · unranked

117 citations

Timothy A. Chan, Alexander M.M. Eggermont, Lorenzo Galluzzi, Guido Kroemer

Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis

Immunity(2023)10.1016/j.immuni.2023.10.010

N/A

0DataRank · unranked

56 citations

Wei Shi, Liangliang Ji, Erik Ladewig, Xian Zhang, Raghvendra M. Srivastava +16 more

KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-1444

N/A

0DataRank · unranked

52 citations

Vladimir Makarov, Jennifer K. Bolzenius, Angela Halstead, Yvonne Parker, Allen Wang +13 more

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2023)10.1172/jci169823

N/A

0DataRank · unranked

31 citations

Mahdi Golkaram, Joris L. Vos, Bin Xu, Conall Fitzgerald, Mark Lee +17 more

Unsupervised and supervised AI on molecular dynamics simulations reveals complex characteristics of HLA-A2-peptide immunogenicity

Briefings in Bioinformatics(2023)10.1093/bib/bbad504

N/A

0DataRank · unranked

15 citations

Joseph A. Morrone, Seung-Gu Kang, Leili Zhang, Lijun Lang, Diego Chowell +8 more

Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors

Trends in cancer(2023)10.1016/j.trecan.2023.07.014

N/A

0DataRank · unranked

22 citations

Timothy A. Chan, Lorenzo Galluzzi, Julie Constanzo, Jean‐Pierre Pouget

Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade

Journal of Clinical Oncology(2023)10.1200/jco.22.02144

N/A

0DataRank · unranked

18 citations

Mahdi Golkaram, Samuel A. Funt, Hikmat Al‐Ahmadie, Shannon Kaplan, Fan Song +11 more

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma

JCI Insight(2023)10.1172/jci.insight.160024

N/A

0DataRank · unranked

6 citations

Matthew M. Grabowski, Balint Otvos, Defne Bayık, Wesley Wang, Ajay Zalavadia +25 more

Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101082

N/A

0DataRank · unranked

6 citations

Lluı́s Espinosa, Hyunsoo Kim, Denise Scholtens, Joseph P. McElroy, Rajani Rajbhandari +34 more

Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0120

N/A

0DataRank · unranked

4 citations

Fengshen Kuo, Vladimir Makarov, Yiyu Dong, Ronald Ghossein, Bin Xu +3 more

Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma

Scientific Reports(2023)10.1038/s41598-023-46476-3

N/A

0DataRank · unranked

1 citations

Peter M. Anderson, Timothy D. Smile, Ahmed Halima, James B. Broughman, C.A. Reddy +13 more

Data from High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

(2023)10.1158/1541-7786.c.6545243

N/A

0DataRank · unranked

2 citations

Renzo G. DiNatale, Diego Chowell, Chirag Krishna, Vladimir Makarov, Cristina Valero +21 more

MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4609

N/A

0DataRank · unranked

1 citations

Karla V. Ballman, Matt D. Galsky, Michael J. Morris, Srikala S. Sridhar, Ronald C. Chen +7 more

Data from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

(2023)10.1158/0008-5472.c.6514364.v1

N/A

0DataRank · unranked

0 citations

Vladimir Makarov, Jennifer K. Bolzenius, Angela Halstead, Yvonne Parker, Allen Wang +13 more

Data from The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

(2023)10.1158/1078-0432.c.6530294

Top 100%

0DataRank

Top 100%0 citations

Evan J. Lipson, Jody E. Hooper, Amanda Zucker, Jungeui Hong, Craig M. Bielski +17 more

Data from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

(2023)10.1158/1078-0432.c.6529017.v1

N/A

0DataRank · unranked

0 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

Data from Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

(2023)10.1158/1541-7786.c.6545222.v1

N/A

0DataRank · unranked

0 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Y. Han, Fengshen Kuo +12 more

Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) in Metastatic Sarcoma

Research Square(2023)10.21203/rs.3.rs-2570832/v1

N/A

0DataRank · unranked

0 citations

Timothy D. Smile, Ahmed Halima, James B. Broughman, C.A. Reddy, Shireen Parsai +13 more

The hallmarks of cancer immune evasion

Cancer Cell(2024)10.1016/j.ccell.2024.09.010

N/A

0DataRank · unranked

504 citations

Timothy A. Chan, Ilio Vitale, Lorenzo Galluzzi, Claudia Galassi

LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses

Science Immunology(2024)10.1126/sciimmunol.adi7418

N/A

0DataRank · unranked

42 citations

Dia Roy, Keman Zhang, Tyler Alban, Ivan Jurić, Juan Dong +14 more

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab

Nature Medicine(2024)10.1038/s41591-024-03240-y

N/A

0DataRank · unranked

35 citations

Nadeem Riaz, Prerana Bangalore Parthasarathy, Vladimir Makarov, Sviatoslav M. Kendall, Seong‐Keun Yoo +16 more

Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae143

N/A

0DataRank · unranked

17 citations

Kanika G. Nair, Shimoli V. Barot, Xiang Shao, Suneel D. Kamath, Marilena Melas +18 more

HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0528

N/A

0DataRank · unranked

7 citations

James J. Ignatz-Hoover, Byung‐Gyu Kim, Ehsan Malek, Yuriy Federov, Drew Adams +3 more

Pre-exposure immunohematologic features of heart failure associate with COVID-19 mortality

npj Cardiovascular Health(2024)10.1038/s44325-024-00025-7

N/A

0DataRank · unranked

2 citations

Brigid Wilson, Sadeer Al‐Kindi, David R. Sweet, Steven Juchnowski, Lauren Huntington +17 more

Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy

Cancer Cell(2025)10.1016/j.ccell.2025.03.006

N/A

0DataRank · unranked

52 citations

Timothy A. Chan, Stephen L. Wang

Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer

Cancer Cell(2025)10.1016/j.ccell.2025.05.010

N/A

0DataRank · unranked

10 citations

Mitesh Patel, Oliver Artz, Georgios Vlachos, Shrey Patel, Omar Hayatt +45 more

Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathway

npj Precision Oncology(2025)10.1038/s41698-025-01093-3

N/A

0DataRank · unranked

4 citations

Emily E. Fink, Hong Qiu, Pierre-Emmanuel Desprez, Arvind Ravi, Mark Holton +9 more

The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs

Nature Communications(2025)10.1038/s41467-025-64983-x

N/A

0DataRank · unranked

4 citations

Pooneh Koochaki, Sayed Matar, Fatme Ghandour, Marc Machaalani, Eddy Saad +22 more

Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signaling

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.06.668464

N/A

0DataRank · unranked

1 citations

George Bukenya, Gavin P. Tannish, Daniel J. Silver, Anu Aggarwal, Juyeun Lee +38 more

MCL1 may not mediate chemoresistance

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.22.671824

N/A

0DataRank · unranked

0 citations

Kunho Chung, Dongmei Zhang, Belinda Willard, Timothy A. Chan, Babal K. Jha +4 more

Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

Nature Cancer(2020)10.1038/s43018-020-00139-8

N/A

0DataRank · unranked

214 citations

Chirag Krishna, Xiaoxiao Ma, Xin Pei, Ken-Wing Lee, Vladimir Makarov +23 more

Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy

Journal of Clinical Investigation(2020)10.1172/jci134402

N/A

0DataRank · unranked

201 citations

Weichao Wang, Yajia Zhang, Marcin Cieślik, Jipeng Guo, Mengyao Tan +20 more

TGF-β suppresses type 2 immunity to cancer

Nature(2020)10.1038/s41586-020-2836-1

N/A

0DataRank · unranked

189 citations

Fengshen Kuo, Kristelle J. Capistrano, Davina Kang, Briana G. Nixon, Wei Shi +11 more

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa184

N/A

0DataRank · unranked

160 citations

Eric J. Sherman, Xin Pei, Heiko Schöder, Milan Grkovski, Ramesh Paudyal +38 more

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group

Annals of Oncology(2020)10.1016/j.annonc.2020.05.008

N/A

0DataRank · unranked

157 citations

Miguél Vázquez, Francesca Finotello, Rosalba Lepore, E. Porta, Jasreet Hundal +10 more

The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians

Annals of Oncology(2020)10.1016/j.annonc.2020.07.002

N/A

0DataRank · unranked

253 citations

David B. Solit, Timothy A. Chan, Razelle Kurzrock, Vivek Subbiah

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0418

N/A

0DataRank · unranked

227 citations

Jiapeng Chen, Joanne F. Chou, Anna M. Varghese, Kenneth H. Yu, Winston Wong +26 more

The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3758

N/A

0DataRank · unranked

126 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

Timothy A. Chan

Indexed papers

Top data-sharing exemplar

Papers